Changeflow GovPing Healthcare & Life Sciences Nucleic Acid Construct Encoding Chimeric Rhodop...
Routine Rule Added Final

Nucleic Acid Construct Encoding Chimeric Rhodopsin - Restore Vision

Favicon for changeflow.com USPTO Patent Grants - Peptides (C07K)
Published
Detected
Email

Summary

USPTO granted Patent US12606606B2 to Restore Vision Inc. for a nucleic acid construct encoding a chimeric rhodopsin protein combining ion-transporting receptor rhodopsin with G protein-coupled receptor rhodopsin sequences. The patent contains 17 claims classified under C07K peptide chemistry and covers applications for preventing retinal diseases and enhancing visual function.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO issued Patent US12606606B2 to Restore Vision Inc., granting exclusive rights to a chimeric rhodopsin nucleic acid construct. The patent covers both the construct composition and methods for preventing and suppressing retinal disease progression while enhancing visual cognitive function.

For competitors in gene therapy, ophthalmic biotechnology, or optogenetic research, this grant signals an existing IP position in chimeric rhodopsin technology for retinal applications. Companies developing similar rhodopsin-based therapies should conduct freedom-to-operate analyses to assess potential infringement exposure.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Nucleic acid construct that encodes chimeric rhodopsin

Grant US12606606B2 Kind: B2 Apr 21, 2026

Assignee

RESTORE VISION INC.

Inventors

Toshihide Kurihara, Yusaku Katada, Kazuo Tsubota, Hideki Kandori

Abstract

Provided are: a nucleic acid including a nucleic acid sequence encoding a chimeric protein including at least part of an ion-transporting receptor rhodopsin and at least part of a G protein-coupled receptor rhodopsin and a nucleic acid sequence encoding a signal sequence; and a nucleic acid including a nucleic acid sequence encoding a chimeric protein including at least part of an ion channeling receptor rhodopsin and at least part of a G protein-coupled receptor rhodopsin; and a nucleic acid construct including the nucleic acid sequences. The use of the nucleic acids or nucleic acid constructs prevents and suppresses the progress of retinal diseases, and enhances the visual cognitive behavioral function and visual function.

CPC Classifications

C07K 2319/00 C07K 2319/43 C07K 19/00 C07K 2319/01 C07K 2319/02 C07K 14/705 C12N 15/63 C12N 15/62 C12N 15/86 C12N 15/861

Filing Date

2020-09-11

Application No.

17642923

Claims

17

View original document →

Get daily alerts for USPTO Patent Grants - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Clinical investigators
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology 6211 Healthcare Providers
Activity scope
Patent issuance Gene therapy research Retinal disease treatment
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!